EUVIMEDEUVIMED entdecken
Crossref

SrcE97A Mediates convergent regulation of arterial/venous thrombosis and immune homeostasis via β3–Src dissociation

Shuang Liu, Jiayi Chen, Yan Shen, Bing Xiao, Yun Wang, Huan Xiong, Zheng Ruan, Jingqiu Liu, Kankan Wang, Cheng Luo, Xiaodong Xi, Jianhua Mao

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2026.06.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Shuang Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collabor…. Hauptthemen laut MEDLINE: Thrombosis, Venous Thrombosis, Integrin beta3, Blood Platelets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Integrin β3 orchestrates thrombotic and inflammatory processes through bidirectional signaling, with Src acting as a key downstream effector. OBJECTIVES: To dissect this axis, we generated SrcE97A mice that selectively disrupt the interaction between Src and integrin β3, impairing outside-in signaling while preserving inside-out signaling through integrin β3. METHODS: Platelet function was assessed through clot retraction, irreversible aggregation, thrombus stabilization under flow, and soluble fibrinogen binding. Thrombosis models included FeCl3-induced carotid artery and laser-induced cremaster arteriole injury for arterial thrombosis, and the inferior vena cava ligation for deep vein thrombosis. Hemostasis was evaluated in parallel. The impact on cerebral infarction was measured in vivo. In addition, the biological functions of αvβ3 outside-in signaling were also analyzed. RESULTS: The SrcE97A mutation impaired outside-in signaling while preserving inside-out signaling in platelets. This suppressed αIIbβ3-mediated clot retraction, secondary aggregation, and thrombus stabilization under flow. SrcE97A mice showed reduced arterial and venous thrombosis without hemostatic compromise. These antithrombotic effects were reinforced by protection against cerebral infarction in vivo. Furthermore, the E97A mutation influenced immunologic regulation. Specifically, it promoted pulmonary inflammation by skewing T helper (Th) cell differentiation toward Th1, via disruption of the αvβ3-Src-STAT4/6 signaling axis. CONCLUSIONS: These findings establish integrin β3 as a dual regulator of thrombosis and immune homeostasis. Selective disruption of outside-in signaling attenuates pathologic thrombosis without compromising hemostasis and reshapes Th1/Th2 balance. Targeting the Src E97 interface may offer strategies to inhibit pathologic thrombosis and modulate inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombosisVenous ThrombosisIntegrin beta3Blood Plateletssrc-Family KinasesAnimalsSignal TransductionHomeostasisDisease Models, AnimalHemostasisPlatelet AggregationMaleCerebral InfarctionMutationMicePlatelet Glycoprotein GPIIb-IIIa ComplexBlood CoagulationMice, Inbred C57BLClot RetractionHumansProtein Binding

Stichwörter der Autor:innen

immune homeostasisintegrin beta3plateletsthrombosis

Substanzen

Integrin beta3src-Family KinasesPlatelet Glycoprotein GPIIb-IIIa Complex

Autor:innen und Institutionen

  • Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao…
  • Research Center for Experimental Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute for Development and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Guangdong, China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Liu, S., Chen, J., Shen, Y., Xiao, B., Wang, Y., Xiong, H., Ruan, Z., Liu, J., Wang, K., Luo, C., Xi, X., & Mao, J. (2026). SrcE97A Mediates convergent regulation of arterial/venous thrombosis and immune homeostasis via β3–Src dissociation. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.06.035

Vancouver

Liu S, Chen J, Shen Y, Xiao B, Wang Y, Xiong H, et al. SrcE97A Mediates convergent regulation of arterial/venous thrombosis and immune homeostasis via β3–Src dissociation. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.06.035

BibTeX
@article{Liu2026,
  author = {Liu, Shuang and Chen, Jiayi and Shen, Yan and Xiao, Bing and Wang, Yun and Xiong, Huan and Ruan, Zheng and Liu, Jingqiu and Wang, Kankan and Luo, Cheng and Xi, Xiaodong and Mao, Jianhua},
  title = {SrcE97A Mediates convergent regulation of arterial/venous thrombosis and immune homeostasis via β3–Src dissociation},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2026.06.035}
}
Kostenlos starten →